Production (Stage)
CervoMed Inc.
CRVO
$7.26
$0.141.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.67M | -16.29M | -11.95M | -5.04M | -4.15M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 91.60K | 200.50K | 410.80K | -2.99M | -3.37M |
| Change in Net Operating Assets | -422.80K | -440.70K | 518.00K | 397.70K | 133.90K |
| Cash from Operations | -19.00M | -16.53M | -11.02M | -7.63M | -7.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.26M | -28.66M | -37.97M | -40.57M | -- |
| Cash from Investing | -23.26M | -28.66M | -37.97M | -40.57M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.41M | 46.41M | 46.41M | 47.22M | 810.00K |
| Repurchase of Common Stock | -13.30K | -13.30K | -13.30K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -93.40K | 10.34M | 10.34M |
| Cash from Financing | 46.40M | 46.40M | 46.31M | 57.56M | 11.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.13M | 1.21M | -2.68M | 9.36M | 3.76M |